ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,747 | -23.0% | 34,436 | +9.2% | 0.00% | – |
| Q2 2023 | $43,838 | +42.9% | 31,538 | +63.5% | 0.00% | – |
| Q1 2023 | $30,671 | -76.3% | 19,290 | -7.0% | 0.00% | – |
| Q4 2022 | $129,198 | +14.3% | 20,738 | +23.0% | 0.00% | – |
| Q3 2022 | $113,000 | +4.6% | 16,856 | -0.8% | 0.00% | – |
| Q2 2022 | $108,000 | +120.4% | 16,998 | +62.1% | 0.00% | – |
| Q1 2022 | $49,000 | -76.3% | 10,487 | +88.6% | 0.00% | – |
| Q3 2020 | $207,000 | -60.0% | 5,559 | -45.0% | 0.00% | – |
| Q2 2020 | $518,000 | +119.5% | 10,110 | +154.9% | 0.00% | – |
| Q4 2019 | $236,000 | -29.3% | 3,966 | -14.1% | 0.00% | – |
| Q1 2018 | $334,000 | +21.9% | 4,618 | +10.8% | 0.00% | – |
| Q4 2017 | $274,000 | – | 4,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |